B-Cell Neoplasm Clinical Trials in Münster, Albert-Schweitzer-Campus 1, Gebaeude A1

Safety and Efficacy Study of Zamtocabtagene Autoleucel (MB-CART2019.1) in Pediatric Patients With R/R B-Cell Neoplasms